A nationwide Mylan EpiPen recall has been issued by Meridian Medical Technologies for 13 lots of Mylan’s EpiPen and EpiPen Jr Auto-Injectors used for the emergency treatment of severe allergic reactions. The auto-injectors could contain a defective part that may result in the device’s failure to activate. Affected patients and their families may be eligible to pursue compensation for damages with the help of a defective medical device attorney.
For more information, contact Attorney Group today. We offer free, confidential, no obligation consultations. We can help answer your questions, and if you choose to pursue a case we can connect you with an affiliated EpiPen recall attorney who can assist you throughout the legal process.
On March 31, 2017, the U.S. Food and Drug Administration (FDA) issued a press announcement alerting consumers of a voluntary recall initiated by Meridian Medical Technologies concerning 13 lots of Mylan’s EpiPen and EpiPen Jr Auto-Injectors, a medical device used for the emergency treatment of severe allergic reactions. According to the FDA, recalled auto-injectors could contain a defective part that may keep the device from activating, leading to life-threatening risks if a severe allergic reaction is left untreated.
Recalled products were manufactured and distributed between December 17, 2015 and July 1, 2016. Auto-injectors subject to recall include:
| Product/Dosage | NDC Number | Lot Number | Expiration Date |
|---|---|---|---|
| EpiPen Jr Auto-Injector, 0.15 mg | 49502-501-02 | 5GN767 | April 2017 |
| EpiPen Jr Auto-Injector, 0.15 mg | 49502-501-02 | 5GN773 | April 2017 |
| EpiPen Auto-Injector, 0.3 mg | 49502-500-02 | 5GM631 | April 2017 |
| EpiPen Auto-Injector, 0.3 mg | 49502-500-02 | 5GM640 | April 2017 |
| EpiPen Jr Auto-Injector, 0.15 mg | 49502-501-02 | 6GN215 | September 2017 |
| EpiPen Auto-Injector, 0.3 mg | 49502-500-02 | 6GM082 | September 2017 |
| EpiPen Auto-Injector, 0.3 mg | 49502-500-02 | 6GM072 | September 2017 |
| EpiPen Auto-Injector, 0.3 mg | 49502-500-02 | 6GM081 | September 2017 |
| EpiPen Auto-Injector, 0.3 mg | 49502-500-02 | 6GM088 | October 2017 |
| EpiPen Auto-Injector, 0.3 mg | 49502-500-02 | 6GM199 | October 2017 |
| EpiPen Auto-Injector, 0.3 mg | 49502-500-02 | 6GM091 | October 2017 |
| EpiPen Auto-Injector, 0.3 mg | 49502-500-02 | 6GM198 | October 2017 |
| EpiPen Auto-Injector, 0.3 mg | 49502-500-02 | 6GM087 | October 2017 |
Although the number of reported failures has been low, the FDA encourages consumers to keep and use their current EpiPens if needed until they have been replaced. If a device fails to activate, patients are advised to seek medical help immediately.
How an EpiPen Recall Attorney Can Help
Medical device makers have a duty to provide safe products. If there are risks of harm associated with their devices, they also must provide adequate warnings. If a device maker fails to fulfill this duty, it could be held liable in lawsuits for injuries that may result.
People injured by a defective EpiPen or EpiPen Jr Auto-Injector may be eligible to recover money for:
- Medical Expenses
- Lost Wages
- Pain and Suffering
The families of those killed may be eligible to recover money for funeral expenses and the pain that comes with losing a loved one.
For more information, contact Attorney Group. After you contact us, an attorney will follow up to answer questions that you might have. There is no cost or obligation to speak with us, and any information you provide will be kept confidential.
Please note that the law limits the time you have to pursue a claim or file a lawsuit for an injury. If you think you have a case, you should not delay taking action.
